Is Hexo (TSX:HEXO) Stock a Buy at its Current Price?

Do you need to consider Hexo stock after its 80% decline since April 2019?

| More on:

We know that cannabis companies have lost considerable value in the last 15 months. Shares of Hexo (TSX:HEXO)(NYSE:HEXO) are currently trading at $1.97 and have lost over 80% since April 2019.

While a few pot stocks have made a comeback in 2020, Hexo has fallen 8.5% year to date. So, why has Hexo been one of the worst-performing pot stocks? Well, similar to peer marijuana companies, Hexo has been impacted by lower-than-expected demand for recreational cannabis products.

Product demand has been subdued due to the slow rollout of retail stores coupled with the cannibalization from illegal sales. Marijuana companies lost market value due to regulatory issues and the vaping scandal as well.

Hexo stock lost 23% in market value on October 10 last year after the company announced preliminary fiscal fourth quarter of 2019 results (year ended in July). Hexo’s sales forecast between $14.5 million and $16.5 million for Q4 was significantly lower than consensus estimates of $25.28 million.

What next for Hexo investors?

In order to take on competition from the illegal market, Hexo launched a low-cost product from its Original Stash brand. It remains to be seen if this move will boost top-line growth significantly for the firm.

The legalization of cannabis-infused edible products is also expected to positively impact sales. The North American market for these products is estimated at $1.56 billion, while the global cannabis-infused beverage market is expected to reach $5.04 billion.

The company’s press release stated, “We continue to prepare to take advantage of opportunities in the cannabis derivatives market and are expecting to launch new products in Canada during the first half of 2020. Products that we intend to introduce include, but are not limited to vapes, edibles such as confectionary and baked goods, cosmetics, and non-alcoholic beverages through our venture with Molson Coors Canada.”

Hexo continues to increase distribution and market penetration across Canada. It has supply agreements with government-run and private retailers in all Canadian provinces and can access 98% of the country’s populace.

Hexo continues to raise capital to support growth. On January 2, 2020, Hexo closed a registered direct offering with institutional investors. Hexo offered 1.49 million shares at an offer price of US$1.67 per share for proceeds of $25 million. It then raised US$20 million on January 22, as it sold 1.19 million shares at an offer price of US$1.67 per share.

Hexo trading at an attractive valuation

Due to its steep decline, Hexo stock is trading at an attractive valuation. It is valued at $506 million, or 6.2 times 2020 sales. It has price-to-book ratio of 0.69.

Analysts expect sales to rise by 70.6% to $81.1 million in 2020 and by 108.4% to $169 million in 2021. We can see that the valuation multiples are more than reasonable considering the company’s growth metrics.

Hexo stock will be volatile, and the upcoming results of cannabis giants, including Aurora Cannabis and Canopy Growth, will be critical for the pot sector as a whole. Analysts tracking Hexo have a 12-month price target of $2.6, indicating upside potential of 32%.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »